SPDYE2B
gene geneOn this page
Summary
SPDYE2B (speedy/RINGO cell cycle regulator family member E2B, HGNC:48334) is a protein-coding gene on chromosome 7q22.1, encoding Speedy protein E2B (A6NHP3).
Predicted to enable protein kinase binding activity.
Source: NCBI Gene 100310812 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001166339
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48334 |
| Approved symbol | SPDYE2B |
| Name | speedy/RINGO cell cycle regulator family member E2B |
| Location | 7q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000173678 |
| Ensembl biotype | protein_coding |
| Entrez | 100310812 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000436228, ENST00000455020, ENST00000507450
RefSeq mRNA: 1 — MANE Select: NM_001166339
NM_001166339
CCDS: CCDS59507
Canonical transcript exons
ENST00000507450 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002443019 | 102656248 | 102656306 |
| ENSE00002449921 | 102651928 | 102652508 |
| ENSE00002455729 | 102653451 | 102653669 |
| ENSE00002464376 | 102650319 | 102650377 |
| ENSE00002486994 | 102657551 | 102657636 |
| ENSE00002488441 | 102659690 | 102660083 |
| ENSE00002501224 | 102654984 | 102655214 |
| ENSE00002507141 | 102660206 | 102660310 |
| ENSE00002518950 | 102661146 | 102662625 |
Expression profiles
Bgee: expression breadth ubiquitous, 133 present calls, max score 77.96.
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.96 | gold quality |
| bone marrow cell | CL:0002092 | 75.27 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 70.34 | gold quality |
| colonic epithelium | UBERON:0000397 | 68.24 | gold quality |
| bone marrow | UBERON:0002371 | 67.15 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 66.36 | silver quality |
| sural nerve | UBERON:0015488 | 65.61 | gold quality |
| blood | UBERON:0000178 | 65.25 | gold quality |
| muscle tissue | UBERON:0002385 | 64.92 | gold quality |
| stromal cell of endometrium | CL:0002255 | 63.04 | gold quality |
| granulocyte | CL:0000094 | 60.15 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 60.11 | gold quality |
| muscle of leg | UBERON:0001383 | 59.83 | gold quality |
| tonsil | UBERON:0002372 | 59.63 | gold quality |
| gastrocnemius | UBERON:0001388 | 59.38 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 57.11 | gold quality |
| leukocyte | CL:0000738 | 56.92 | gold quality |
| vermiform appendix | UBERON:0001154 | 56.62 | gold quality |
| monocyte | CL:0000576 | 56.60 | gold quality |
| right uterine tube | UBERON:0001302 | 55.76 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 55.32 | gold quality |
| liver | UBERON:0002107 | 54.92 | gold quality |
| ventricular zone | UBERON:0003053 | 54.34 | gold quality |
| urinary bladder | UBERON:0001255 | 54.06 | gold quality |
| stomach | UBERON:0000945 | 54.05 | gold quality |
| heart left ventricle | UBERON:0002084 | 54.00 | gold quality |
| cortex of kidney | UBERON:0001225 | 53.50 | gold quality |
| small intestine | UBERON:0002108 | 53.47 | gold quality |
| mucosa of stomach | UBERON:0001199 | 53.20 | gold quality |
| apex of heart | UBERON:0002098 | 53.08 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.17 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
12 targeting SPDYE2B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-363-5P | 99.46 | 64.51 | 1015 |
| HSA-MIR-4769-3P | 97.95 | 68.17 | 1002 |
| HSA-MIR-6817-5P | 97.95 | 67.86 | 1026 |
| HSA-MIR-6747-3P | 97.73 | 64.84 | 1596 |
| HSA-MIR-22-5P | 97.67 | 68.92 | 1355 |
| HSA-MIR-7154-3P | 97.65 | 65.02 | 985 |
| HSA-MIR-346 | 97.01 | 66.97 | 662 |
| HSA-MIR-6736-3P | 96.98 | 65.22 | 1342 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spdye4b | ENSMUSG00000029586 |
| mus_musculus | Spdye4a | ENSMUSG00000039296 |
| rattus_norvegicus | Spdye4 | ENSRNOG00000058563 |
Paralogs (18): SPDYE1 (ENSG00000136206), SPDYE5 (ENSG00000170092), SPDYE4 (ENSG00000183318), SPDYE12 (ENSG00000184616), SPDYE16 (ENSG00000185040), SPDYE17 (ENSG00000186645), SPDYE2 (ENSG00000205238), SPDYE18 (ENSG00000205482), SPDYE3 (ENSG00000214300), SPDYE21 (ENSG00000230358), SPDYE6 (ENSG00000260097), SPDYE9 (ENSG00000262461), SPDYE8 (ENSG00000273520), SPDYE10 (ENSG00000274570), SPDYE11 (ENSG00000275976), SPDYE15 (ENSG00000286014), SPDYE13 (ENSG00000286038), SPDYE14 (ENSG00000286137)
Protein
Protein identifiers
Speedy protein E2B — A6NHP3 (reviewed: A6NHP3)
All UniProt accessions (1): A6NHP3
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the Speedy/Ringo family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A6NHP3-1 | 1 | yes |
| A6NHP3-2 | 2 |
RefSeq proteins (1): NP_001159811* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR020984 | Speedy | Family |
| IPR057742 | Speedy_E | Family |
Pfam: PF11357
UniProt features (5 total): compositionally biased region 2, chain 1, region of interest 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NHP3-F1 | 61.12 | 0.25 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 5 (showing top):
GOMF_KINASE_BINDING, LU_EZH2_TARGETS_DN, MIR6736_3P, MIR346, chr7q22
GO Biological Process (1): positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)
GO Molecular Function (1): protein kinase binding (GO:0019901)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of cyclin-dependent protein serine/threonine kinase activity | 1 |
| cyclin-dependent protein serine/threonine kinase activity | 1 |
| positive regulation of cell cycle | 1 |
| positive regulation of protein serine/threonine kinase activity | 1 |
| positive regulation of cyclin-dependent protein kinase activity | 1 |
| kinase binding | 1 |
Protein interactions and networks
STRING
20 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPDYE2B | NUTM2G | Q5VZR2 | 102 |
| SPDYE2B | SPDYE1 | Q8NFV5 | 0 |
| SPDYE2B | CDK2 | P24941 | 0 |
| SPDYE2B | CDC25C | P30307 | 0 |
| SPDYE2B | SPDYA | Q5MJ70 | 0 |
| SPDYE2B | SPDYC | Q5MJ68 | 0 |
| SPDYE2B | CDK1 | P06493 | 0 |
| SPDYE2B | SPDYE2 | Q495Y8 | 0 |
| SPDYE2B | SPDYE5 | A6NIY4 | 0 |
| SPDYE2B | SPDYE6 | P0CI01 | 0 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPDYE2B | PCNA | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (5): SPDYE2B (Two-hybrid), SPDYE2B (Two-hybrid), SPDYE2B (Two-hybrid), KRTAP17-1 (Two-hybrid), SPDYE2B (Negative Genetic)
ESM2 similar proteins: A0A0J9YY54, A0A494C086, A0A494C0Z2, A0A494C191, A6NHP3, A6NIY4, A6NJR5, A6NNV3, B4DH59, F6SZT2, P0C6Y7, P0CI01, P0DKJ7, P0DKJ8, P0DTA3, P0DUD1, P0DUD2, P0DUD3, P0DUD4, P0DUX0, P0DUX1, P0DV79, P79386, Q08AG5, Q13342, Q16666, Q3BBV2, Q495Y8, Q587J8, Q5JRC9, Q5QGU6, Q5RD14, Q5RKG3, Q63HK3, Q6ITT4, Q7TQI8, Q86T75, Q8IWY8, Q8N660, Q8NFV5
Diamond homologs: A0A494C086, A0A494C0Z2, A0A494C191, A6NHP3, A6NIY4, A6NJR5, A6NKU9, A6NLX3, A6NNV3, P0CI01, P0DTA3, P0DUD1, P0DUD2, P0DUD3, P0DUD4, P0DUX0, P0DUX1, P0DV79, Q495Y7, Q495Y8, Q5IBH6, Q5IBH7, Q5MJ68, Q5MJ70, Q8NFV5, Q8R496, Q9PU13, Q9YGL1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1444 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:102656246:A:AG | acceptor_gain | 0.9900 |
| 7:102656247:G:GG | acceptor_gain | 0.9900 |
| 7:102659688:A:AG | acceptor_gain | 0.9900 |
| 7:102659689:G:GA | acceptor_gain | 0.9900 |
| 7:102659689:GCT:G | acceptor_gain | 0.9900 |
| 7:102659759:G:GT | donor_gain | 0.9900 |
| 7:102660080:GGAG:G | donor_gain | 0.9900 |
| 7:102660081:GAGG:G | donor_gain | 0.9900 |
| 7:102660083:GGTG:G | donor_loss | 0.9900 |
| 7:102660084:G:GA | donor_loss | 0.9900 |
| 7:102660085:T:A | donor_loss | 0.9900 |
| 7:102651982:GCTT:G | donor_gain | 0.9800 |
| 7:102652475:G:GT | donor_gain | 0.9800 |
| 7:102652480:G:GA | donor_gain | 0.9800 |
| 7:102655207:GCTGC:G | donor_gain | 0.9800 |
| 7:102656246:AGAG:A | acceptor_gain | 0.9800 |
| 7:102656247:GAGG:G | acceptor_gain | 0.9800 |
| 7:102657637:G:GG | donor_gain | 0.9800 |
| 7:102659684:CCTCA:C | acceptor_loss | 0.9800 |
| 7:102659685:CTCA:C | acceptor_loss | 0.9800 |
| 7:102659686:TCAGC:T | acceptor_loss | 0.9800 |
| 7:102659687:CA:C | acceptor_loss | 0.9800 |
| 7:102659689:GCTAC:G | acceptor_gain | 0.9800 |
| 7:102652479:T:TA | donor_gain | 0.9700 |
| 7:102652506:CAG:C | donor_loss | 0.9700 |
| 7:102652507:AGG:A | donor_loss | 0.9700 |
| 7:102652508:GGTGA:G | donor_loss | 0.9700 |
| 7:102652509:G:GA | donor_loss | 0.9700 |
| 7:102653665:GCTTG:G | donor_gain | 0.9700 |
| 7:102655163:C:T | donor_gain | 0.9700 |
AlphaMissense
2662 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:102656268:T:C | F211L | 0.989 |
| 7:102656270:C:A | F211L | 0.989 |
| 7:102656270:C:G | F211L | 0.989 |
| 7:102655199:T:C | F199L | 0.987 |
| 7:102655201:C:A | F199L | 0.987 |
| 7:102655201:C:G | F199L | 0.987 |
| 7:102656269:T:C | F211S | 0.980 |
| 7:102657578:T:C | F233L | 0.979 |
| 7:102657580:C:A | F233L | 0.979 |
| 7:102657580:C:G | F233L | 0.979 |
| 7:102659732:A:C | K266N | 0.975 |
| 7:102659732:A:T | K266N | 0.975 |
| 7:102656281:A:T | D215V | 0.971 |
| 7:102656281:A:C | D215A | 0.970 |
| 7:102657626:T:C | F249L | 0.967 |
| 7:102657628:C:A | F249L | 0.967 |
| 7:102657628:C:G | F249L | 0.967 |
| 7:102655200:T:C | F199S | 0.962 |
| 7:102656302:A:T | D222V | 0.962 |
| 7:102656272:T:C | L212S | 0.961 |
| 7:102660238:G:C | W394C | 0.956 |
| 7:102660238:G:T | W394C | 0.956 |
| 7:102656280:G:C | D215H | 0.955 |
| 7:102659748:T:C | F272L | 0.954 |
| 7:102659750:C:A | F272L | 0.954 |
| 7:102659750:C:G | F272L | 0.954 |
| 7:102657579:T:C | F233S | 0.945 |
| 7:102656282:C:A | D215E | 0.944 |
| 7:102656282:C:G | D215E | 0.944 |
| 7:102655209:T:C | L202P | 0.943 |
dbSNP variants (sampled 300 via entrez): RS1044151489 (7:102656362 C>T), RS1059798 (7:102661090 T>C), RS111553311 (7:102660858 A>G), RS111656884 (7:102657102 G>A), RS111666395 (7:102662788 T>C), RS111737170 (7:102654961 C>G,T), RS111757010 (7:102661671 G>T), RS112021919 (7:102652675 C>T), RS112094731 (7:102654733 A>C,G), RS112209185 (7:102662477 C>T), RS112380295 (7:102651696 T>C), RS112436737 (7:102648963 C>T), RS112471566 (7:102651577 C>T), RS112521196 (7:102652251 C>T), RS112548817 (7:102648666 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| cordycepin | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.